Logo image of CELH

CELSIUS HOLDINGS INC (CELH) Stock Fundamental Analysis

NASDAQ:CELH - Nasdaq - US15118V2079 - Common Stock - Currency: USD

32.62  +7.09 (+27.77%)

After market: 32.3975 -0.22 (-0.68%)

Fundamental Rating

6

Overall CELH gets a fundamental rating of 6 out of 10. We evaluated CELH against 31 industry peers in the Beverages industry. While CELH has a great health rating, its profitability is only average at the moment. CELH is valued quite expensively, but it does show have an excellent growth rating. These ratings could make CELH a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CELH was profitable.
CELH had a positive operating cash flow in the past year.
Of the past 5 years CELH 4 years were profitable.
Of the past 5 years CELH 4 years had a positive operating cash flow.
CELH Yearly Net Income VS EBIT VS OCF VS FCFCELH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

CELH has a better Return On Assets (9.98%) than 71.43% of its industry peers.
The Return On Equity of CELH (13.63%) is comparable to the rest of the industry.
CELH's Return On Invested Capital of 12.81% is fine compared to the rest of the industry. CELH outperforms 67.86% of its industry peers.
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROIC 12.81%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A
CELH Yearly ROA, ROE, ROICCELH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

CELH has a better Profit Margin (12.41%) than 67.86% of its industry peers.
In the last couple of years the Profit Margin of CELH has grown nicely.
CELH has a better Operating Margin (17.01%) than 60.71% of its industry peers.
CELH's Operating Margin has improved in the last couple of years.
CELH has a Gross Margin (49.59%) which is comparable to the rest of the industry.
CELH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%
CELH Yearly Profit, Operating, Gross MarginsCELH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CELH is creating some value.
The number of shares outstanding for CELH has been increased compared to 1 year ago.
The number of shares outstanding for CELH has been increased compared to 5 years ago.
CELH has a worse debt/assets ratio than last year.
CELH Yearly Shares OutstandingCELH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CELH Yearly Total Debt VS Total AssetsCELH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

CELH has an Altman-Z score of 10.01. This indicates that CELH is financially healthy and has little risk of bankruptcy at the moment.
CELH has a better Altman-Z score (10.01) than 85.71% of its industry peers.
The Debt to FCF ratio of CELH is 0.00, which is an excellent value as it means it would take CELH, only 0.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CELH (0.00) is better than 89.29% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CELH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, CELH belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.01
ROIC/WACC1.4
WACC9.14%
CELH Yearly LT Debt VS Equity VS FCFCELH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

CELH has a Current Ratio of 4.71. This indicates that CELH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CELH (4.71) is better than 96.43% of its industry peers.
A Quick Ratio of 4.03 indicates that CELH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.03, CELH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.71
Quick Ratio 4.03
CELH Yearly Current Assets VS Current LiabilitesCELH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The earnings per share for CELH have decreased strongly by -10.78% in the last year.
CELH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 91.57% yearly.
The Revenue has grown by 101.65% in the past year. This is a very strong growth!
The Revenue has been growing by 90.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-10.78%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-17.65%
Revenue 1Y (TTM)101.65%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-4.38%

3.2 Future

Based on estimates for the next years, CELH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.08% on average per year.
CELH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.32% yearly.
EPS Next Y-10.95%
EPS Next 2Y9.49%
EPS Next 3Y13.09%
EPS Next 5Y17.08%
Revenue Next Year4.45%
Revenue Next 2Y9.78%
Revenue Next 3Y10.64%
Revenue Next 5Y12.32%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CELH Yearly Revenue VS EstimatesCELH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CELH Yearly EPS VS EstimatesCELH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 47.28 indicates a quite expensive valuation of CELH.
Based on the Price/Earnings ratio, CELH is valued a bit more expensive than the industry average as 67.86% of the companies are valued more cheaply.
CELH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
CELH is valuated quite expensively with a Price/Forward Earnings ratio of 35.18.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CELH indicates a slightly more expensive valuation: CELH is more expensive than 64.29% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CELH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 47.28
Fwd PE 35.18
CELH Price Earnings VS Forward Price EarningsCELH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CELH is valued a bit more expensive than 67.86% of the companies in the same industry.
60.71% of the companies in the same industry are cheaper than CELH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 45.19
EV/EBITDA 17.53
CELH Per share dataCELH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of CELH may justify a higher PE ratio.
A more expensive valuation may be justified as CELH's earnings are expected to grow with 13.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.49%
EPS Next 3Y13.09%

0

5. Dividend

5.1 Amount

CELH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CELSIUS HOLDINGS INC

NASDAQ:CELH (2/21/2025, 8:07:08 PM)

After market: 32.3975 -0.22 (-0.68%)

32.62

+7.09 (+27.77%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-26 2025-02-26/amc
Inst Owners72.45%
Inst Owner Change1.5%
Ins Owners26.74%
Ins Owner Change-0.72%
Market Cap7.67B
Analysts79.26
Price Target39.19 (20.14%)
Short Float %24.88%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP16.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-42.81%
Min EPS beat(2)-100%
Max EPS beat(2)14.38%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-100%
Max EPS beat(4)36.12%
EPS beat(8)6
Avg EPS beat(8)-4.8%
EPS beat(12)9
Avg EPS beat(12)19.52%
EPS beat(16)11
Avg EPS beat(16)17.26%
Revenue beat(2)1
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-10.55%
Max Revenue beat(4)2.75%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)5.71%
Revenue beat(16)13
Avg Revenue beat(16)8.1%
PT rev (1m)-4.82%
PT rev (3m)-14.36%
EPS NQ rev (1m)-14.41%
EPS NQ rev (3m)-20.82%
EPS NY rev (1m)-2.31%
EPS NY rev (3m)-7.88%
Revenue NQ rev (1m)-3.09%
Revenue NQ rev (3m)-4.68%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-2.94%
Valuation
Industry RankSector Rank
PE 47.28
Fwd PE 35.18
P/S 5.59
P/FCF 45.19
P/OCF 39.85
P/B 6.14
P/tB 6.27
EV/EBITDA 17.53
EPS(TTM)0.69
EY2.12%
EPS(NY)0.93
Fwd EY2.84%
FCF(TTM)0.72
FCFY2.21%
OCF(TTM)0.82
OCFY2.51%
SpS5.83
BVpS5.31
TBVpS5.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.98%
ROE 13.63%
ROCE 16.48%
ROIC 12.81%
ROICexc N/A
ROICexgc N/A
OM 17.01%
PM (TTM) 12.41%
GM 49.59%
FCFM 12.38%
ROA(3y)-1.06%
ROA(5y)2.87%
ROE(3y)-1.49%
ROE(5y)3.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y36.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y62%
ROICexc growth 5YN/A
OM growth 3Y51%
OM growth 5YN/A
PM growth 3Y28.53%
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y3.67%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 379.26%
Cap/Sales 1.66%
Interest Coverage 250
Cash Conversion 80.45%
Profit Quality 99.75%
Current Ratio 4.71
Quick Ratio 4.03
Altman-Z 10.01
F-Score7
WACC9.14%
ROIC/WACC1.4
Cap/Depr(3y)407.35%
Cap/Depr(5y)253.69%
Cap/Sales(3y)1.2%
Cap/Sales(5y)0.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.78%
EPS 3Y91.57%
EPS 5YN/A
EPS Q2Q%-17.65%
EPS Next Y-10.95%
EPS Next 2Y9.49%
EPS Next 3Y13.09%
EPS Next 5Y17.08%
Revenue 1Y (TTM)101.65%
Revenue growth 3Y116.05%
Revenue growth 5Y90.45%
Sales Q2Q%-4.38%
Revenue Next Year4.45%
Revenue Next 2Y9.78%
Revenue Next 3Y10.64%
Revenue Next 5Y12.32%
EBIT growth 1Y27.71%
EBIT growth 3Y226.22%
EBIT growth 5YN/A
EBIT Next Year-9.66%
EBIT Next 3Y13.82%
EBIT Next 5Y14.89%
FCF growth 1Y38.83%
FCF growth 3Y253.59%
FCF growth 5YN/A
OCF growth 1Y52.16%
OCF growth 3Y246.31%
OCF growth 5YN/A